Perimeter Solutions, Inc.
PRMPerimeter Solutions, Inc. is strength at full price. The numbers are improving — and a P/E at the 99th percentile of its own range says the market knows.
The sharpest disagreement: profits are rising, but only −25% of the last 2 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (19 weeks in) while the P/E sits at the 99th percentile of its own 3-year range. Underneath, the last four quarters read improving — profit +16.7% year on year, and −25% of the last 2 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Perimeter Solutions, Inc. trades at $33.3, in a confirmed uptrend and 19 weeks into that stage. That is +17.1% against its own 200-day average. It sits at 76% of a 52-week range of $19 to $38. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 1 straight week.
Today the stock is in a confirmed uptrend — week 19 of stage 2. At $33.3 it trades +17.1% versus its 200-day average and sits at 76% of its 52-week range ($19–$38).
Against the market, two honest reads. Cumulative: over the last 4.7 years the stock moved +137% while the S&P 500 moved +65% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Perimeter Solutions, Inc. trades at 72.5× P/E, about the priciest it has ever traded. Its long-run median P/E is 19.7×, measured across 3.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 72.5× is about the priciest it has ever traded, against a long-run median of 19.7× measured over 3.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The price move, decomposed: over 3y, of the +77.1%/yr price move, ~+8.4%/yr came from earnings growth and ~+68.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Perimeter Solutions, Inc. reads as turning around on its fundamental arc. Turning around — profit growth swung from −100.0% at the trough to +16.7%, a 2-quarter improving streak (single-quarter readings), ROE slipping at -18.6%. The read is built from 12 quarters across 3 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +16.1% | +21.8% | — | — |
| Stock price | +112.6% | +77.1% | — | — |
4-Factor Sector Score
40.4/100 — rank 22 of 29 in Specialty Chemicals · 58% evidence confidence
Perimeter Solutions, Inc. scores 40.4 out of 100 against the 29 companies it is compared with in Specialty Chemicals, ranking 22. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 10 + 7.5 + 9 + 13.9 = 40.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Perimeter Solutions, Inc. reported $0.1 B of revenue in the Mar 26 quarter, +85.7% year on year. That is the 10th straight quarter of year-on-year growth. Over 4 years it has compounded at 46.8% a year. The last full year, FY25, came in at $0.7 B. The last four reported quarters add to $0.7 B.
FY25 revenue came in at $0.7 B (+16.1% on the year), capping 4 years at 46.8% compound. The latest quarter (Mar 26) printed $0.1 B, +85.7% year on year — the 10th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +32.6% growth against the decade's 46.8% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +22.4% over the last 4 quarters against +44.5%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Perimeter Solutions, Inc.'s operating margin is 53.8% in the Mar 26 quarter, −60.5 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −492.9% to 36.1%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 53.8%, −60.5 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −492.9%–36.1%.
🚨 Why the margin moved: operating margin went −60.5 pp year on year while gross margin went −4.4 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Perimeter Solutions, Inc. earned $0.1 B of net profit in the Mar 26 quarter, +16.7% year on year. The full FY25 year was a loss of $0.2 B. That is 53.8% of the quarter's revenue. The same quarter a year earlier earned $0.1 B. 6 of the last 12 reported quarters were loss-making.
Mar 26 profit was $0.1 B, +16.7% year on year. On the full year, FY25 printed $−0.2 B (null).
Why profit moved: revenue contributed +85.7% and the margin −60.5 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −144.4% vs revenue +32.6%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 2 fiscal years −25% of Perimeter Solutions, Inc.'s reported profit arrived as operating cash — a gap worth watching. In FY25 that was $0.2 B of operating cash against $−0.2 B of profit. After $0.0 B of capital spending, $0.2 B was left as free cash.
FY25: operating cash of $0.2 B against reported profit of $−0.2 B, leaving free cash of $0.2 B after $0.0 B of capital spending. Across the last 2 fiscal years the conversion rate is −25% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Perimeter Solutions, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Perimeter Solutions, Inc. earns a ROE of −19% in FY25. That is up from a trough of −61% in FY21. Return on invested capital clears the cost of that capital by −28.0 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −32.3% net margin on 0.25× asset turns.
FY25 ROE is −19%, recovered from a FY21 trough of −61% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY25): −32.3% net margin × 0.25× asset turns × 2.35× balance-sheet leverage ≈ −19.0% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: −15.5% − 12.5% = a −28.0 pp spread. The 12.5% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend
Perimeter Solutions, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Perimeter Solutions, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Perimeter Solutions, Inc. carries total debt of $1.3 B against shareholder equity of $1.0 B as of Jun 26, a debt-to-equity of 1.23. On the annual view that ratio went from 0.59 in FY21 to 0.62 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of $1.3 B against shareholder equity of $1.0 B — a debt-to-equity of 1.23. On the annual view, debt-to-equity went from 0.59 (FY21) to 0.62 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
3.1% of Perimeter Solutions, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 2.5 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 3.1% of the float is sold short, and at typical trading volumes it would take about 2.5 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Perimeter Solutions, Inc.: the Z-score reads 0.56. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 0.56 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 0.56.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1NewMarket CorporationNEU | 61.9/100Thin evidence · provisional58% evidence | BREAKING OUT | 16.9/35 Revenue — · PAT — · OPM change -1.4 pp 45% evidence | 16.1/25 ROCE 5.5% · OPM 21.4% 76% evidence | 11.4/20 P/E 17× · PEG — 15% evidence | 17.5/20 RS sector 5.4% · RS bench 8.6% · 1Y 20.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 16.1 + 11.4 + 17.5 = 61.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Sociedad Química y Minera de Chile S.A.SQM | 61.7/100Mixed-positive evidence81% evidence | ASLEEP | 28.8/35 Revenue 18.3% · PAT 48.4% · OPM change 17.4 pp 83% evidence | 15.8/25 ROCE 6.3% · OPM 41% 76% evidence | 15.1/20 P/E 28.4× · PEG 0.81 65% evidence | 2.0/20 RS sector -9.7% · RS bench -8.3% · 1Y 62.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 28.8 + 15.8 + 15.1 + 2 = 61.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -9.7% and the one-year return is 62.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3WD-40 CompanyWDFC | 61.3/100Thin evidence · provisional58% evidence | TURNING | 21.3/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 17.4/25 ROCE 10.8% · OPM 16.3% 76% evidence | 10.2/20 P/E 30.4× · PEG — 15% evidence | 12.4/20 RS sector -3.7% · RS bench -1.4% · 1Y 7.5%5 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 17.4 + 10.2 + 12.4 = 61.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Sensient Technologies CorporationSXT | 60.7/100Thin evidence · provisional58% evidence | FADING | 20.4/35 Revenue — · PAT — · OPM change 1.7 pp 45% evidence | 12.8/25 ROCE 3.8% · OPM 15.3% 76% evidence | 9.8/20 P/E 33.2× · PEG — 15% evidence | 17.7/20 RS sector 7.9% · RS bench 10.5% · 1Y 9%8 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 12.8 + 9.8 + 17.7 = 60.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Quaker Chemical CorporationKWR | 57.5/100Thin evidence · provisional58% evidence | BREAKING OUT | 21.5/35 Revenue — · PAT — · OPM change 0.8 pp 45% evidence | 8.3/25 ROCE 1.7% · OPM 7% 76% evidence | 10.5/20 P/E 28.3× · PEG — 15% evidence | 17.2/20 RS sector 6% · RS bench 8.7% · 1Y 36.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 8.3 + 10.5 + 17.2 = 57.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Axalta Coating Systems Ltd.AXTA | 56.2/100Thin evidence · provisional58% evidence | BREAKING OUT | 15.3/35 Revenue — · PAT — · OPM change -2.3 pp 45% evidence | 11.7/25 ROCE 2.8% · OPM 11.6% 76% evidence | 10.8/20 P/E 21.1× · PEG — 15% evidence | 18.4/20 RS sector 6.4% · RS bench 9.2% · 1Y 32.5%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 11.7 + 10.8 + 18.4 = 56.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Ashland Inc.ASH | 54.2/100Thin evidence · provisional58% evidence | BREAKING OUT | 18.8/35 Revenue — · PAT — · OPM change -2.5 pp 45% evidence | 7.0/25 ROCE 1% · OPM 8.1% 76% evidence | 8.9/20 P/E 57.8× · PEG — 15% evidence | 19.5/20 RS sector 10.3% · RS bench 12.9% · 1Y 39%9 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 7 + 8.9 + 19.5 = 54.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8The Sherwin-Williams CompanySHW | 53.8/100Thin evidence · provisional58% evidence | TURNING | 18.7/35 Revenue — · PAT — · OPM change -0.1 pp 45% evidence | 15.5/25 ROCE 7.1% · OPM 14.2% 76% evidence | 10.0/20 P/E 31.7× · PEG — 15% evidence | 9.6/20 RS sector -6.6% · RS bench -4% · 1Y 2.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 15.5 + 10 + 9.6 = 53.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9H.B. Fuller CompanyFUL | 53.0/100Mixed-positive evidence85% evidence | BASING | 22.1/35 Revenue -0.6% · PAT 80.6% · OPM change 1.2 pp 95% evidence | 10.9/25 ROCE 2.6% · OPM 12.3% 76% evidence | 16.1/20 P/E 19× · PEG 0.5 65% evidence | 3.9/20 RS sector -14.3% · RS bench -12.2% · 1Y 4.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 10.9 + 16.1 + 3.9 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10International Flavors & Fragrances Inc.IFF | 52.4/100Mixed-positive evidence64% evidence | ASLEEP | 21.5/35 Revenue -5.6% · PAT — · OPM change 41.8 pp 62% evidence | 7.2/25 ROCE 1.2% · OPM 10% 76% evidence | 10.6/20 P/E 22.2× · PEG — 15% evidence | 13.1/20 RS sector 0% · RS bench 2.2% · 1Y 27.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 7.2 + 10.6 + 13.1 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Eastman Chemical CompanyEMN | 52.4/100Thin evidence · provisional58% evidence | ASLEEP | 18.6/35 Revenue — · PAT — · OPM change -4.6 pp 45% evidence | 13.3/25 ROCE 4.8% · OPM 8.6% 76% evidence | 11.2/20 P/E 17.4× · PEG — 15% evidence | 9.3/20 RS sector -5.5% · RS bench -3.5% · 1Y 19.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 13.3 + 11.2 + 9.3 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Avient CorporationAVNT | 52.2/100Mixed-positive evidence64% evidence | ASLEEP | 21.8/35 Revenue 1.3% · PAT 56.9% · OPM change 11.2 pp 62% evidence | 9.1/25 ROCE 1.9% · OPM 11.3% 76% evidence | 10.9/20 P/E 21.1× · PEG — 15% evidence | 10.4/20 RS sector -4.6% · RS bench -2.6% · 1Y 16.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 9.1 + 10.9 + 10.4 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Balchem CorporationBCPC | 52.2/100Thin evidence · provisional58% evidence | TURNING | 18.6/35 Revenue — · PAT — · OPM change 0.1 pp 45% evidence | 14.6/25 ROCE 3.8% · OPM 20.5% 76% evidence | 9.9/20 P/E 33.2× · PEG — 15% evidence | 9.1/20 RS sector -5.8% · RS bench -3.6% · 1Y 9.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 14.6 + 9.9 + 9.1 = 52.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14RPM International Inc.RPM | 50.2/100Thin evidence · provisional58% evidence | TURNING | 18.3/35 Revenue — · PAT — · OPM change 0.8 pp 45% evidence | 12.7/25 ROCE 4.8% · OPM 5% 76% evidence | 11.0/20 P/E 20.5× · PEG — 15% evidence | 8.2/20 RS sector -8.3% · RS bench -5.8% · 1Y -3.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 12.7 + 11 + 8.2 = 50.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15PPG Industries, Inc.PPG | 50.2/100Thin evidence · provisional58% evidence | TURNING | 16.8/35 Revenue — · PAT — · OPM change -0.2 pp 45% evidence | 12.8/25 ROCE 3.6% · OPM 13.8% 76% evidence | 11.3/20 P/E 17.4× · PEG — 15% evidence | 9.3/20 RS sector -5.7% · RS bench -3.5% · 1Y 10.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 12.8 + 11.3 + 9.3 = 50.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Element Solutions IncESI | 49.8/100Thin evidence · provisional58% evidence | ASLEEP | 17.7/35 Revenue — · PAT — · OPM change 0.3 pp 45% evidence | 10.6/25 ROCE 2.3% · OPM 13.3% 76% evidence | 8.8/20 P/E 64.5× · PEG — 15% evidence | 12.7/20 RS sector 6.6% · RS bench 8.2% · 1Y 62.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 10.6 + 8.8 + 12.7 = 49.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Linde plcLIN | 47.5/100Thin evidence · provisional58% evidence | ASLEEP | 18.8/35 Revenue — · PAT — · OPM change 0.9 pp 45% evidence | 14.3/25 ROCE 3.6% · OPM 27.8% 76% evidence | 9.7/20 P/E 33.5× · PEG — 15% evidence | 4.7/20 RS sector -10.3% · RS bench -8.3% · 1Y 2.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 14.3 + 9.7 + 4.7 = 47.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Ecolab Inc.ECL | 46.7/100Thin evidence · provisional58% evidence | TURNING | 17.0/35 Revenue — · PAT — · OPM change 0.3 pp 45% evidence | 12.9/25 ROCE 3.5% · OPM 15.3% 76% evidence | 9.5/20 P/E 37.4× · PEG — 15% evidence | 7.3/20 RS sector -9% · RS bench -6.6% · 1Y 3.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 12.9 + 9.5 + 7.3 = 46.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Cabot CorporationCBT | 46.3/100Mixed-negative evidence81% evidence | ASLEEP | 8.9/35 Revenue -8.5% · PAT -31.2% · OPM change -3 pp 83% evidence | 13.3/25 ROCE 4.5% · OPM 14.3% 76% evidence | 16.5/20 P/E 14.2× · PEG 0.18 65% evidence | 7.6/20 RS sector -5.2% · RS bench -3.1% · 1Y 5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 8.9 + 13.3 + 16.5 + 7.6 = 46.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 20Air Products and Chemicals, Inc.APD | 43.7/100Thin evidence · provisional58% evidence | BASING | 17.0/35 Revenue — · PAT — · OPM change 103.5 pp 45% evidence | 9.5/25 ROCE -5.8% · OPM 23.7% 76% evidence | 10.1/20 P/E 30.7× · PEG — 15% evidence | 7.1/20 RS sector -7% · RS bench -4.9% · 1Y 2.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 9.5 + 10.1 + 7.1 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Calumet, Inc.CLMT | 41.5/100Mixed-negative evidence64% evidence | BREAKING OUT | 9.4/35 Revenue -0.1% · PAT — · OPM change -11.7 pp 62% evidence | 3.0/25 ROCE -9.1% · OPM -16.6% 76% evidence | 10.3/20 P/E 30.3× · PEG — 15% evidence | 18.8/20 RS sector 40.5% · RS bench 42% · 1Y 189.2%9 of 12 weeks ahead 100% evidence |
| Exact sum: 9.4 + 3 + 10.3 + 18.8 = 41.5 · Decision use: Price leads the evidence: RS versus the benchmark is 42%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 22Perimeter Solutions, Inc.this pagePRM | 40.4/100Thin evidence · provisional58% evidence | FADING | 10.0/35 Revenue — · PAT — · OPM change -50 pp 45% evidence | 7.5/25 ROCE -7.6% · OPM 58% 76% evidence | 9.0/20 P/E 53.3× · PEG — 15% evidence | 13.9/20 RS sector 7.8% · RS bench 10.3% · 1Y 84.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 10 + 7.5 + 9 + 13.9 = 40.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23DuPont de Nemours, Inc.DD | 38.9/100Mixed-negative evidence81% evidence | BASING | 22.2/35 Revenue 4% · PAT 40.7% · OPM change 5.2 pp 83% evidence | 7.5/25 ROCE 0.7% · OPM 11.1% 76% evidence | 4.3/20 P/E 45.4× · PEG 4.12 65% evidence | 4.9/20 RS sector -21.8% · RS bench -19.3% · 1Y -32.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 7.5 + 4.3 + 4.9 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Albemarle CorporationALB | 38.3/100Thin evidence · provisional53% evidence | ASLEEP | 20.0/35 Revenue — · PAT — · OPM change 14.5 pp 32% evidence | 9.2/25 ROCE 1.6% · OPM 16.3% 76% evidence | 9.1/20 P/E 47.9× · PEG — 15% evidence | 0.0/20 RS sector -22.9% · RS bench -21.8% · 1Y 60.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 9.2 + 9.1 + 0 = 38.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25Hawkins, Inc.HWKN | 37.8/100Thin evidence · provisional58% evidence | ASLEEP | 14.8/35 Revenue — · PAT — · OPM change -1.2 pp 45% evidence | 12.7/25 ROCE 4.4% · OPM 8.8% 76% evidence | 9.4/20 P/E 41.9× · PEG — 15% evidence | 0.9/20 RS sector -22.8% · RS bench -20.8% · 1Y -24.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 12.7 + 9.4 + 0.9 = 37.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26LyondellBasell Industries N.V.LYB | 33.4/100Adverse evidence71% evidence | ASLEEP | 13.1/35 Revenue -9.4% · PAT -164.8% · OPM change 1.8 pp 83% evidence | 6.5/25 ROCE 0.9% · OPM 3.3% 76% evidence | 8.6/20 P/E 76.1× · PEG — 15% evidence | 5.2/20 RS sector -5.6% · RS bench -4.2% · 1Y 24.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 6.5 + 8.6 + 5.2 = 33.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27The Chemours CompanyCC | 28.8/100Adverse evidence64% evidence | ASLEEP | 12.7/35 Revenue 0.6% · PAT -3836.4% · OPM change -2 pp 62% evidence | 4.4/25 ROCE 0.5% · OPM 1.9% 76% evidence | 8.5/20 P/E 225.5× · PEG — 15% evidence | 3.2/20 RS sector -7.7% · RS bench -6.6% · 1Y 47.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 12.7 + 4.4 + 8.5 + 3.2 = 28.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Westlake CorporationWLK | 26.1/100Adverse evidence64% evidence | BASING | 9.8/35 Revenue -8.6% · PAT -473.1% · OPM change -5.4 pp 62% evidence | 4.7/25 ROCE -1% · OPM -6.5% 76% evidence | 9.6/20 P/E 33.6× · PEG — 15% evidence | 2.0/20 RS sector -17.5% · RS bench -16.2% · 1Y 2.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 9.8 + 4.7 + 9.6 + 2 = 26.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Solstice Advanced Materials, Inc.SOLS | 46.2/100Thin evidence · provisional36% evidence | ASLEEP | 12.4/35 Revenue — · PAT — · OPM change -4.5 pp 39% evidence | 15.1/25 ROCE 9.6% · OPM 16.5% 76% evidence | 8.7/20 P/E 67.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —1 of 12 weeks ahead 0% evidence |
| Exact sum: 12.4 + 15.1 + 8.7 + 10 = 46.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Perimeter Solutions, Inc.'s stock price today?
Perimeter Solutions, Inc. trades at $33.3, +112.6% over the past year. The company is valued at $5.0 B. The stock sits at 76% of its 52-week range of $19–$38, +17.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 19 weeks in. — as of 5 August 2026.
What were Perimeter Solutions, Inc.'s latest quarterly results?
Perimeter Solutions, Inc. reported revenue of $0.1 B and net profit of $0.1 B for the Mar 26 quarter. Revenue rose 85.7% and profit rose 16.7% year on year. Earnings per share were $0.44. The operating margin was 53.8%, 60.5 pp lower than a year earlier. — as of 5 August 2026.
What is Perimeter Solutions, Inc.'s revenue?
Perimeter Solutions, Inc. reported revenue of $0.1 B in the Mar 26 quarter, +85.7% year on year. For the full FY25 fiscal year, revenue was $0.7 B (+16.1%). Over the last 4 years revenue compounded at 46.8% a year. — as of 5 August 2026.
What is Perimeter Solutions, Inc.'s profit?
Perimeter Solutions, Inc. earned $0.1 B of net profit in the Mar 26 quarter, +16.7% year on year. Full-year FY25 profit was $−0.2 B. The operating margin ran 53.8% in the latest quarter. — as of 5 August 2026.
What is Perimeter Solutions, Inc.'s market cap?
Perimeter Solutions, Inc.'s market capitalisation is $5.0 B at a stock price of $33.3. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Perimeter Solutions, Inc.'s P/E ratio?
Perimeter Solutions, Inc. trades at a P/E of 72.5×, at the 99th percentile of its own 3-year range, against a long-run median of 19.7×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Perimeter Solutions, Inc. pay a dividend?
No — Perimeter Solutions, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is Perimeter Solutions, Inc. overvalued?
On its own history, Perimeter Solutions, Inc. looks expensive against its own history: its P/E of 72.5× sits at the 99th percentile of its 3-year range (long-run median 19.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
Is Perimeter Solutions, Inc. growing?
Yes — Perimeter Solutions, Inc. is growing: latest-quarter revenue +85.7% year on year, profit +16.7%, and the margin −60.5 pp at 53.8%. The earnings engine currently reads: improving — as of 5 August 2026.
How is Perimeter Solutions, Inc. performing?
Perimeter Solutions, Inc. is in a confirmed uptrend, 19 weeks in. Its latest quarter's revenue rose 85.7% and profit rose 16.7% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Perimeter Solutions, Inc. in?
Turning around — profit growth swung from −100.0% at the trough to +16.7%, a 2-quarter improving streak (single-quarter readings), ROE slipping at -18.6%. The read comes from the last 12 quarters of growth (revenue growth +22.4% latest, profit growth +16.7% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Perimeter Solutions, Inc. in an uptrend?
Yes — the price is in a confirmed uptrend (week 19 of stage 2), trading +17.1% versus its 200-day average and at 76% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Perimeter Solutions, Inc. beating the market?
On recent form, yes — Perimeter Solutions, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 4.7 years the stock moved +137% against the S&P 500's +65% — ahead of the index over the full window. — as of 5 August 2026.
Will Perimeter Solutions, Inc.'s stock price go up?
This page publishes no price forecast for Perimeter Solutions, Inc. What it measures instead: the stock price is $33.3, the price is in a confirmed uptrend 19 weeks in. Its P/E of 72.5× sits at the 99th percentile of its own 3-year range. — as of 5 August 2026.
Is the market betting against Perimeter Solutions, Inc.?
Somewhat — short interest is 3.1% of Perimeter Solutions, Inc.'s tradable float, about 2.5 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Perimeter Solutions, Inc. have too much debt?
It carries real leverage — Perimeter Solutions, Inc.'s debt-to-equity is 1.35. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Perimeter Solutions, Inc.'s capex?
Perimeter Solutions, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 5 August 2026.
What is Perimeter Solutions, Inc.'s cash flow?
Perimeter Solutions, Inc. generated $0.2 B of operating cash flow in FY25 and $0.2 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $−0.2 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Perimeter Solutions, Inc.'s profit real cash?
Not fully — over the last 2 fiscal years, −25% of Perimeter Solutions, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $0.2 B against reported profit of $−0.2 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Perimeter Solutions, Inc.?
On the balance sheet, the Z-score reads 0.56 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is Perimeter Solutions, Inc. in its business cycle?
Perimeter Solutions, Inc.'s FY25 operating margin was −30.8%, against a 5-year band of −492.9%–36.1%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 53.8%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Perimeter Solutions, Inc. story?
The sharpest disagreement: profits are rising, but only −25% of the last 2 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Perimeter Solutions, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Perimeter Solutions, Inc. is strength at full price. The numbers are improving — and a P/E at the 99th percentile of its own range says the market knows. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.